Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
Cancer Treat Rev. 2022 Nov;110:102460. doi: 10.1016/j.ctrv.2022.102460. Epub 2022 Aug 27.
Cancer Treat Rev. 2022.
PMID: 36058142
Review.
Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.
Bregni G, Trevisi E, Saúde Conde R, Vanhooren M, Akin Telli T, Assaf I, Hendlisz A, Di Maio M, Sclafani F.
Bregni G, et al. Among authors: vanhooren m.
J Natl Cancer Inst. 2023 May 8;115(5):505-513. doi: 10.1093/jnci/djad030.
J Natl Cancer Inst. 2023.
PMID: 36762842
Free PMC article.
Item in Clipboard
Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer.
Assaf I, Fimereli D, Anthoine G, Fazio R, Daprà V, Audisio A, Bardiaux A, Telli TA, Vanhooren M, Saude-Conde R, Bregni G, Hendlisz A, Sclafani F.
Assaf I, et al. Among authors: vanhooren m.
Cancers (Basel). 2023 Dec 13;15(24):5823. doi: 10.3390/cancers15245823.
Cancers (Basel). 2023.
PMID: 38136368
Free PMC article.
Item in Clipboard
Cite
Cite